Dong M - Search Results

1

A novel immune score model predicting the prognosis and immunotherapy response of breast cancer.

Lv W, He X, Wang Y, Zhao C, Dong M, Wu Y, Zhang Q. Lv W, et al. Among authors: dong m. Sci Rep. 2023 Apr 19;13(1):6403. doi: 10.1038/s41598-023-31153-2. Sci Rep. 2023. PMID: 37076508 Free PMC article.

2

Extracellular Vesicles: The Landscape in the Progression, Diagnosis, and Treatment of Triple-Negative Breast Cancer.

Dong M, Liu Q, Xu Y, Zhang Q. Dong M, et al. Front Cell Dev Biol. 2022 Mar 1;10:842898. doi: 10.3389/fcell.2022.842898. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35300426 Free PMC article. Review.

3

Development of a prognostic signature based on immune-related genes and the correlation with immune microenvironment in breast cancer.

Dong M, Cui X, Wang G, Zhang Q, Li X. Dong M, et al. Aging (Albany NY). 2022 Jul 5;14(13):5427-5448. doi: 10.18632/aging.204158. Epub 2022 Jul 5. Aging (Albany NY). 2022. PMID: 35793235 Free PMC article.

4

The emerging roles and mechanism of m6a in breast cancer progression.

Zhou M, Dong M, Yang X, Gong J, Liao X, Zhang Q, Liu Z. Zhou M, et al. Among authors: dong m. Front Genet. 2022 Aug 10;13:983564. doi: 10.3389/fgene.2022.983564. eCollection 2022. Front Genet. 2022. PMID: 36035182 Free PMC article. Review.

5

Down-regulated lncRNA SBF2-AS1 inhibits tumorigenesis and progression of breast cancer by sponging microRNA-143 and repressing RRS1.

Xia W, Liu Y, Cheng T, Xu T, Dong M, Hu X. Xia W, et al. Among authors: dong m. J Exp Clin Cancer Res. 2020 Jan 17;39(1):18. doi: 10.1186/s13046-020-1520-5. J Exp Clin Cancer Res. 2020. PMID: 31952549 Free PMC article.

6

ZW10 interacting kinetochore protein may serve as a prognostic biomarker for human breast cancer: An integrated bioinformatics analysis.

Li HN, Zheng WH, Du YY, Wang G, Dong ML, Yang ZF, Li XR. Li HN, et al. Oncol Lett. 2020 Mar;19(3):2163-2174. doi: 10.3892/ol.2020.11353. Epub 2020 Jan 24. Oncol Lett. 2020. PMID: 32194714 Free PMC article.

7

Elevated mRNA expression levels of DLGAP5 are associated with poor prognosis in breast cancer.

Xu T, Dong M, Li H, Zhang R, Li X. Xu T, et al. Among authors: dong m. Oncol Lett. 2020 Jun;19(6):4053-4065. doi: 10.3892/ol.2020.11533. Epub 2020 Apr 10. Oncol Lett. 2020. PMID: 32391106 Free PMC article.

8

Elevated mRNA Expression Levels of NCAPG are Associated with Poor Prognosis in Ovarian Cancer.

Xu T, Dong M, Wang Z, Li H, Li X. Xu T, et al. Among authors: dong m. Cancer Manag Res. 2020 Jul 14;12:5773-5786. doi: 10.2147/CMAR.S253349. eCollection 2020. Cancer Manag Res. 2020. PMID: 32765080 Free PMC article.

9

Chloride intracellular channel protein 2: prognostic marker and correlation with PD-1/PD-L1 in breast cancer.

Xu T, Wang Z, Dong M, Wu D, Liao S, Li X. Xu T, et al. Among authors: dong m. Aging (Albany NY). 2020 Sep 11;12(17):17305-17327. doi: 10.18632/aging.103712. Epub 2020 Sep 11. Aging (Albany NY). 2020. PMID: 32915772 Free PMC article.

10

NCAPG upregulation mediated by four microRNAs combined with activation of the p53 signaling pathway is a predictor of poor prognosis in patients with breast cancer.

Dong M, Xu T, Cui X, Li H, Li X, Xia W. Dong M, et al. Oncol Lett. 2021 Apr;21(4):323. doi: 10.3892/ol.2021.12585. Epub 2021 Feb 23. Oncol Lett. 2021. PMID: 33692855 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,444 results

Search Page

Filters